These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 11510469

  • 1. The t(4;14)(p16.3;q32) is strongly associated with chromosome 13 abnormalities in both multiple myeloma and monoclonal gammopathy of undetermined significance.
    Fonseca R, Oken MM, Greipp PR, Eastern Cooperative Oncology Group Myeloma Group.
    Blood; 2001 Aug 15; 98(4):1271-2. PubMed ID: 11510469
    [No Abstract] [Full Text] [Related]

  • 2. t(4;14)(p16.3;q32) is strongly associated with a shorter survival in myeloma patients.
    Winkler JM, Greipp P, Fonseca R.
    Br J Haematol; 2003 Jan 15; 120(1):170-1. PubMed ID: 12492597
    [No Abstract] [Full Text] [Related]

  • 3. Genomic abnormalities in monoclonal gammopathy of undetermined significance.
    Fonseca R, Bailey RJ, Ahmann GJ, Rajkumar SV, Hoyer JD, Lust JA, Kyle RA, Gertz MA, Greipp PR, Dewald GW.
    Blood; 2002 Aug 15; 100(4):1417-24. PubMed ID: 12149226
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Characterization of the t(4;14)(p16.3;q32) in the KMS-18 multiple myeloma cell line.
    Ronchetti D, Bogni S, Finelli P, Lombardi L, Otsuki T, Maiolo AT, Neri A.
    Leukemia; 2001 May 15; 15(5):864-5. PubMed ID: 11368454
    [No Abstract] [Full Text] [Related]

  • 7. Identification of a novel IGH-MMSET fusion transcript in a human myeloma cell line with the t(4;14)(p16.3;q32) chromosomal translocation.
    Intini D, Fabris S, Storlazzi T, Otsuki T, Ciceri G, Verdelli D, Lombardi L, Rocchi M, Neri A.
    Br J Haematol; 2004 Aug 15; 126(3):437-9. PubMed ID: 15257719
    [No Abstract] [Full Text] [Related]

  • 8. 14q32 translocations and monosomy 13 observed in monoclonal gammopathy of undetermined significance delineate a multistep process for the oncogenesis of multiple myeloma. Intergroupe Francophone du Myélome.
    Avet-Loiseau H, Facon T, Daviet A, Godon C, Rapp MJ, Harousseau JL, Grosbois B, Bataille R.
    Cancer Res; 1999 Sep 15; 59(18):4546-50. PubMed ID: 10493504
    [Abstract] [Full Text] [Related]

  • 9. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.
    Chesi M, Nardini E, Brents LA, Schröck E, Ried T, Kuehl WM, Bergsagel PL.
    Nat Genet; 1997 Jul 15; 16(3):260-4. PubMed ID: 9207791
    [Abstract] [Full Text] [Related]

  • 10. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.
    Keats JJ, Reiman T, Maxwell CA, Taylor BJ, Larratt LM, Mant MJ, Belch AR, Pilarski LM.
    Blood; 2003 Feb 15; 101(4):1520-9. PubMed ID: 12393535
    [Abstract] [Full Text] [Related]

  • 11. Expression of fibroblast growth factor and FGF-receptor family genes in human myeloma cells, including lines possessing t(4;14)(q16.3;q32. 3) and FGFR3 translocation.
    Otsuki T, Yamada O, Yata K, Sakaguchi H, Kurebayashi J, Nakazawa N, Taniwaki M, Yawata Y, Ueki A.
    Int J Oncol; 1999 Dec 15; 15(6):1205-12. PubMed ID: 10568829
    [Abstract] [Full Text] [Related]

  • 12. Mutation, SNP, and isoform analysis of fibroblast growth factor receptor 3 (FGFR3) in 150 newly diagnosed multiple myeloma patients.
    Onwuazor ON, Wen XY, Wang DY, Zhuang L, Masih-Khan E, Claudio J, Barlogie B, Shaughnessy JD, Stewart AK.
    Blood; 2003 Jul 15; 102(2):772-3. PubMed ID: 12835230
    [No Abstract] [Full Text] [Related]

  • 13. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
    López-Corral L, Gutiérrez NC, Vidriales MB, Mateos MV, Rasillo A, García-Sanz R, Paiva B, San Miguel JF.
    Clin Cancer Res; 2011 Apr 01; 17(7):1692-700. PubMed ID: 21325290
    [Abstract] [Full Text] [Related]

  • 14. Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses.
    Fabris S, Agnelli L, Mattioli M, Baldini L, Ronchetti D, Morabito F, Verdelli D, Nobili L, Intini D, Callea V, Stelitano C, Lombardi L, Neri A.
    Genes Chromosomes Cancer; 2005 Feb 01; 42(2):117-27. PubMed ID: 15543617
    [Abstract] [Full Text] [Related]

  • 15. Analysis of FGFR3 gene mutations in multiple myeloma patients with t(4;14).
    Intini D, Baldini L, Fabris S, Lombardi L, Ciceri G, Maiolo AT, Neri A.
    Br J Haematol; 2001 Aug 01; 114(2):362-4. PubMed ID: 11529856
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
    Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M.
    Blood; 1997 Jul 15; 90(2):526-34. PubMed ID: 9226151
    [Abstract] [Full Text] [Related]

  • 18. FGFR3 gene mutations associated with human skeletal disorders occur rarely in multiple myeloma.
    Fracchiolla NS, Luminari S, Baldini L, Lombardi L, Maiolo AT, Neri A.
    Blood; 1998 Oct 15; 92(8):2987-9. PubMed ID: 9763594
    [No Abstract] [Full Text] [Related]

  • 19. A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript.
    Santra M, Zhan F, Tian E, Barlogie B, Shaughnessy J.
    Blood; 2003 Mar 15; 101(6):2374-6. PubMed ID: 12433679
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.